Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Hospira vs Epogen in Hemodialysis Patients
NCT01473407Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2012
- Primary completion
- Feb 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of Epoetin alfa RB in anemia of chronic kidney disease, sponsored by Pfizer. Started Jan 2012; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT01473407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473407.